Thymalin vs Vilon
A side-by-side research comparison of Thymalin and Vilon across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Thymalin | Vilon |
|---|---|---|
| Full name | Thymalin (Thymus Extract Peptide) | Vilon (Lys-Glu Dipeptide Immune Bioregulator) |
| Category | Immune Support | Immune Support |
| Status | Research compound | Research compound (peptide bioregulator) |
| Mechanism | Contains bioactive thymic peptides that regulate T-lymphocyte differentiation, restore T-helper/T-suppressor ratios, and enhance phagocyte activity and interferon production. | As a very short signal peptide (Lys-Glu), it is proposed to bind DNA and modulate gene expression in immune and other tissues, influencing chromatin activity, cytokine balance, and cellular aging markers. |
| Molecular weight | ~1000-5000 Da (complex mixture) | ~275 Da |
| Half-life | ~4-6 hours | Short (peptide) |
| Bioavailability | ~80% intramuscular | Oral (encapsulated) or subcutaneous |
| Typical dose | 5-10 mg | ~1-2 capsules/day or short injectable courses |
| Frequency | Daily for 5-10 days | Once daily |
| Route | Intramuscular injection | Oral capsule or subcutaneous |
Thymalin reported benefits
- Immune reconstitution
- T-cell ratio normalization
- Interferon production
- Anti-tumor immunity support
Vilon reported benefits
- Immune regulation support
- Gene-expression modulation (proposed)
- Anti-aging tissue effects (proposed)
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.